The protein encoded by this gene is highly homologous to alpha-synuclein. These proteins are abundantly expressed in the brain and putatively inhibit phospholipase D2 selectively. The encoded protein, which may play a role in neuronal plasticity, is abundant in neurofibrillary lesions of patients with Alzheimer disease. This protein has been shown to be highly expressed in the substantia nigra of the brain, a region of neuronal degeneration in patients with Parkinson disease\; however, no direct relation to Parkinson disease has been established. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008].
Irvine, El-Agnaf, Shankar, Walsh: "Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases." in: Molecular medicine (Cambridge, Mass.), Vol. 14, Issue 7-8, pp. 451-64, (2008) (PubMed).
Wakabayashi, Tanji, Mori, Takahashi: "The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates." in: Neuropathology : official journal of the Japanese Society of Neuropathology, Vol. 27, Issue 5, pp. 494-506, (2007) (PubMed).
Hashimoto, Bar-On, Ho, Takenouchi, Rockenstein, Crews, Masliah: "Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease." in: The Journal of biological chemistry, Vol. 279, Issue 22, pp. 23622-9, (2004) (PubMed).
George: "The synucleins." in: Genome biology, Vol. 3, Issue 1, pp. REVIEWS3002, (2002) (PubMed).
Bruening, Giasson, Klein-Szanto, Lee, Trojanowski, Godwin: "Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary." in: Cancer, Vol. 88, Issue 9, pp. 2154-63, (2000) (PubMed).